{"filing":{"accession_number":"0001104659-26-075198","cik":"0001477845","ticker":"ANVS","company_name":"Annovis Bio, Inc.","form":"8-K","filing_date":"2026-06-17","report_date":null,"primary_document":"tm2617993d2_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1477845/000110465926075198/tm2617993d2_8k.htm"},"events":[{"id":11625,"run_id":10210,"accession_number":"0001104659-26-075198","anchor_item_number":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This 8-K discloses the results of Annovis Bio's 2026 Annual Meeting of Stockholders held on June 17, 2026, under Item 5.07. The filing reports voting outcomes for five proposals: election of five directors, ratification of Ernst \u0026 Young LLP as independent auditors, amendment to the 2019 Equity Incentive Plan to increase authorized shares, advisory vote on named executive officer compensation, and advisory vote on the frequency of future compensation votes. All proposals were approved. This is a routine but material shareholder vote disclosure required by Item 5.07 of Form 8-K.","company_name":"Annovis Bio, Inc.","ticker":"ANVS","filing_date":"2026-06-17","submitted_at":null,"items":null}],"classifications":[{"id":8268,"accession_number":"0001104659-26-075198","item_number":null,"item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This 8-K discloses the results of Annovis Bio's 2026 Annual Meeting of Stockholders held on June 17, 2026, under Item 5.07. The filing reports voting outcomes for five proposals: election of five directors, ratification of Ernst \u0026 Young LLP as independent auditors, amendment to the 2019 Equity Incentive Plan to increase authorized shares, advisory vote on named executive officer compensation, and advisory vote on the frequency of future compensation votes. All proposals were approved. This is a routine but material shareholder vote disclosure required by Item 5.07 of Form 8-K.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-17T20:52:06.673821+00:00","company_name":"Annovis Bio, Inc.","ticker":"ANVS","filing_date":"2026-06-17"}]}